UB Paderborn / Katalog / Suche / in CDI

1 – 12 von 12

Sortiert nach

Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2180-2188

2013

Volltextzugriff (PDF)

Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer

Drug metabolism and disposition, 2008-02, Vol.36 (2), p.205

2008

Volltextzugriff (PDF)

DNA methylation dynamics in the hepatic CYP3A4 gene promoter

Biochimie, 2012-11, Vol.94 (11), p.2338-2344

2012

Volltextzugriff (PDF)

Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function

Genome biology, 2013-08, Vol.14 (8), p.R83-R83

2013

Volltextzugriff (PDF)

Extrahepatic Cancer Suppresses Nuclear Receptor―Regulated Drug Metabolism

Clinical cancer research, 2011-05, Vol.17 (10), p.3170-3180

2011

Volltextzugriff (PDF)

In-solution hybrid capture of bisulfite-converted DNA for targeted bisulfite sequencing of 174 ADME genes

Nucleic acids research, 2013-04, Vol.41 (6), p.e72

2013

Volltextzugriff (PDF)

Epigenetic-dependent regulation of drug transport and metabolism: an update

Pharmacogenomics, 2012-09, Vol.13 (12), p.1373-1385

2012

Volltextzugriff (PDF)

Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer

Clinical colorectal cancer, 2008-09, Vol.7 (5), p.331-337

2008

Volltextzugriff (PDF)

Extra-Hepatic Cancer Represses Hepatic Drug Metabolism Via Interleukin (IL)-6 Signalling

Pharmaceutical research, 2013-09, Vol.30 (9), p.2270-2278

2013

Volltextzugriff (PDF)

Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing

Expert opinion on drug metabolism & toxicology, 2008-02, Vol.4 (2), p.137-149

2008

Volltextzugriff (PDF)

Extra-Hepatic Cancer Represses Hepatic Drug Metabolism Via Interleukin (IL)-6 Signalling : Disease, Drug Metabolism, and Transporter Interactions

Pharmaceutical research, 2013, Vol.30 (9), p.2270-2278

2013

Volltextzugriff (PDF)

EXTRA-HEPATIC CANCER SUPPRESSES NUCLEAR RECEPTOR REGULATED DRUG METABOLISM

Clinical cancer research, 2011-04, Vol.17 (10), p.3170-3180

2011

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(8)
Animals
(5)
Liver - Metabolism
(5)
Dna Methylation
(4)
Male
(4)
Medicin Och Hälsovetenskap
(4)
Pharmaceutical Preparations - Metabolism
(4)
Pharmacology & Pharmacy
(4)
Adult
(3)
Biochemistry & Molecular Biology
(3)
Female
(3)
Neoplasms - Metabolism
(3)
Aged
(2)
Biological And Medical Sciences
(2)
Cancer
(2)
Cyp3a4
(2)
Cytochrome P-450 Cyp3a - Genetics
(2)
Cytochrome P-450 Enzyme System - Metabolism
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?

Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer

DNA methylation dynamics in the hepatic CYP3A4 gene promoter

Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function

Extrahepatic Cancer Suppresses Nuclear Receptor―Regulated Drug Metabolism

In-solution hybrid capture of bisulfite-converted DNA for targeted bisulfite sequencing of 174 ADME genes

Epigenetic-dependent regulation of drug transport and metabolism: an update

Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer

Extra-Hepatic Cancer Represses Hepatic Drug Metabolism Via Interleukin (IL)-6 Signalling

Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing

Extra-Hepatic Cancer Represses Hepatic Drug Metabolism Via Interleukin (IL)-6 Signalling : Disease, Drug Metabolism, and Transporter Interactions

EXTRA-HEPATIC CANCER SUPPRESSES NUCLEAR RECEPTOR REGULATED DRUG METABOLISM

Suchergebnisse filtern